Jennison Associates LLC Heron Therapeutics, Inc. Transaction History

Jennison Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$23.15 - $28.34 $5.32 Million - $6.51 Million	-229,626 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$22.03 - $32.01 $56,727 - $82,425	2,575 Added 1.13%	229,626 $5.96 Million
Q3 2018 Nov 08, 2018	BUY	$30.0 - $40.85 $61,530 - $83,783	2,051 Added 0.91%	227,051 $7.19 Million
Q2 2018 Aug 02, 2018	BUY	$26.4 - $42.0 $5.94 Million - $9.45 Million	225,000 New	225,000 $8.74 Million

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $201M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.